한글목차

척추용 생물학적 제제 시장 규모는 최근 몇 년간 크게 성장했습니다. 2025년 24억 7,000만 달러에서 2026년에는 26억 1,000만 달러에 이르고, CAGR 5.5%의 성장이 전망되고 있습니다. 지난 수년간의 성장은 퇴행성 척추질환의 유병률 증가, 척추 고정술 건수 증가, 기존 골이식술의 한계, 고령화 인구 증가, 생물학적 제제를 통한 수술 성적 향상 등이 원인으로 추정됩니다.

척추용 생물학적 제제 시장 규모는 향후 몇 년간, 꾸준한 성장이 전망됩니다. 2030년에는 31억 7,000만 달러에 이르고, CAGR은 5.0%를 나타낼 전망입니다. 예측 기간 동안 성장 요인으로는 재생의료 솔루션에 대한 수요 증가, 최소침습 척추 수술 증가, 수술 후 합병증 감소에 대한 집중 강화, 생물학적 재료의 기술 발전, 정형외과 의료비 지출 증가 등을 꼽을 수 있습니다. 예측 기간 동안 주요 동향으로는 척추 고정술에서 생체 골 이식재 채택 증가, 합성 골 이식 대체재 사용 확대, 최소 침습 척추 수술 선호도 증가, 세포 기반 및 재생 의료를 통한 척추 치료 확대, 빠른 뼈 치유 솔루션에 대한 수요 증가 등을 들 수 있습니다.

향후 몇 년 동안 교통사고 발생률 증가가 척추용 생물학적 제제 시장의 성장을 견인할 것으로 예측됩니다. 교통사고는 공공 도로에서 차량이 의도치 않게 충돌하는 사고를 의미하며, 고도의 생물학적 치료가 필요한 외상성 척추 손상의 주요 원인입니다. 교통사고율 증가는 교통량 증가, 운전 중 주의 산만, 음주운전, 불충분한 도로 인프라 등의 요인에 기인합니다. 척추용 생물학적 제제는 척추 고정을 촉진하고, 뼈 치유를 가속화하며, 수술 합병증을 최소화하고, 장기적인 기능적 예후를 개선하여 환자의 회복을 돕습니다. 예를 들어, 프랑스에 본부를 둔 정부 간 기구인 국제교통포럼(ITF)에 따르면, 2025년 8월 현재 호주는 2024년 교통사고 사망자 수가 1,297명으로 2023년에 비해 4% 증가했다고 보고했습니다. 그 결과, 증가하는 교통사고 건수가 척추용 생물학적 제제 시장 확대에 기여하고 있습니다.

척추용 생물학적 제제 시장의 주요 기업들은 척추 고정술의 성과와 수술 효율을 향상시키기 위해 재생 의료용 바이오로직스 등 혁신적인 솔루션 개발에 주력하고 있습니다. 재생의료용 바이오로직스는 손상된 조직의 복구, 재생, 대체를 돕는 천연 또는 인공 생체 유래 물질로 제조된 의료용 제품입니다. 예를 들어, 2025년 10월 캐나다에 본사를 둔 제조업체인 오로라 스파인 코퍼레이션(Aurora Spine Corporation)은 척추 고정술의 성공률을 높이기 위한 전문 부문인 '오로라 바이오로직스'를 통해 새로운 바이오로직스 제품군을 발표했습니다. 이 제품군에는 척추 고정술의 결과를 최적화하기 위해 설계된 'TURBO FUSE Fiber Putty'와 'OSTEO BRIDGE Sponge Strips'와 같은 100% 동종 이식골 제품들이 포함되어 있습니다. 이러한 생물학적 제제는 오로라의 최소침습 척추 임플란트 기술과 결합하여 수술의 효율성과 환자의 장기적인 회복을 촉진합니다. 이번 출시로 오로라의 생물학적 제제 제품군이 30% 이상 확대되어 성장을 가속하고 복잡한 척추 치료를 단순화한다는 회사의 사명을 뒷받침할 수 있게 되었습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 공급망 분석

제4장 세계 시장 동향과 전략

제5장 최종 이용 산업 시장 분석

제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의의 공급망에 대한 영향, 코로나 팬데믹이 시장에 미치는 영향을 포함한 거시경제 시나리오

제7장 세계 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석

제8장 TAM(Total Addressable Market) 규모

제9장 시장 세분화

제10장 지역별/국가별 분석

제11장 아시아태평양 시장

제12장 중국 시장

제13장 인도 시장

제14장 일본 시장

제15장 호주 시장

제16장 인도네시아 시장

제17장 한국 시장

제18장 대만 시장

제19장 동남아시아 시장

제20장 서유럽 시장

제21장 영국 시장

제22장 독일 시장

제23장 프랑스 시장

제24장 이탈리아 시장

제25장 스페인 시장

제26장 동유럽 시장

제27장 러시아 시장

제28장 북미 시장

제29장 미국 시장

제30장 캐나다 시장

제31장 남미 시장

제32장 브라질 시장

제33장 중동 시장

제34장 아프리카 시장

제35장 시장 규제 상황과 투자환경

제36장 경쟁 구도와 기업 개요

제37장 기타 주요 기업 및 혁신 기업

제38장 세계 시장 경쟁 벤치마킹과 대시보드

제39장 주요 인수합병(M&A)

제40장 시장 잠재력이 높은 국가, 부문, 전략

제41장 부록

영문목차

Spine biologics, also referred to as spinal biologics, are materials derived from biological sources that are used to address spinal conditions and injuries. These materials help promote bone growth, accelerate healing, and enhance the results of spine surgeries, especially spinal fusion procedures. They encompass a range of products, including bone grafts, growth factors, cell-based therapies, and biological scaffolds.

The primary products in spine biologics include bone allografts, bone graft substitutes, platelet-rich plasma, and bone marrow aspirate therapy. Bone allografts are grafts obtained from a donor instead of the patient's own body. Various surgical procedures, such as anterior cervical discectomy and fusion (ACDF), posterior lumbar interbody fusion (PLIF), transforaminal lumbar interbody fusion (TLIF), anterior lumbar interbody fusion (ALIF), lateral lumbar interbody fusion (LLIF), and others, utilize spine biologics for applications including spinal fusion, spinal non-union and fracture repair, degenerative disc disease treatment, and more. These products are used by multiple end users, including hospitals, spinal surgery centers, orthopedic clinics, and others.

Tariffs have impacted the spine biologics market by increasing costs for imported biologic materials, processed bone grafts, and specialized surgical components. These effects are most pronounced in advanced biologic products and in regions dependent on cross-border medical material sourcing. Elevated tariffs may raise procedure costs and limit adoption in cost-sensitive healthcare systems. However, tariffs are also encouraging domestic production, local sourcing of graft materials, and innovation in synthetic

The spine biologics market research report is one of a series of new reports from The Business Research Company that provides spine biologics market statistics, including spine biologics industry global market size, regional shares, competitors with a spine biologics market share, detailed spine biologics market segments, market trends and opportunities, and any further data you may need to thrive in the spine biologics industry. This spine biologics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The spine biologics market size has grown strongly in recent years. It will grow from $2.47 billion in 2025 to $2.61 billion in 2026 at a compound annual growth rate (CAGR) of 5.5%. The growth in the historic period can be attributed to increasing prevalence of degenerative spine disorders, rising number of spinal fusion surgeries, limitations of traditional bone grafts, growing aging population, improving surgical outcomes with biologics.

The spine biologics market size is expected to see steady growth in the next few years. It will grow to $3.17 billion in 2030 at a compound annual growth rate (CAGR) of 5.0%. The growth in the forecast period can be attributed to expanding demand for regenerative medicine solutions, growth in minimally invasive spine surgeries, increasing focus on reducing post-surgical complications, technological advancements in biologic materials, rising healthcare spending on orthopedic care. Major trends in the forecast period include rising adoption of biologic bone grafts in spinal fusion, increasing use of synthetic bone graft substitutes, growing preference for minimally invasive spine procedures, expansion of cell-based and regenerative spine therapies, higher demand for faster bone healing solutions.

The increasing incidence of road accidents is anticipated to drive the growth of the spinal biologics market in the coming years. A road accident is an unintended collision involving vehicles on public roads and represents a significant cause of traumatic spinal injuries that often require advanced biologic treatments. The rise in road accident rates is attributed to factors such as higher traffic volumes, distracted driving, impaired driving, and insufficient road infrastructure. Spinal biologics aid patient recovery by promoting spinal fusion, accelerating bone healing, minimizing surgical complications, and enhancing long-term functional outcomes. For example, in August 2025, according to the International Transport Forum, a France-based intergovernmental organization, Australia reported 1,297 road deaths in 2024, representing a 4% increase compared to 2023. Consequently, the growing number of road accidents is contributing to the expansion of the spinal biologics market.

Major companies in the spinal biologics market are concentrating on developing innovative solutions, such as regenerative biologics, to enhance spinal fusion results and surgical efficiency. Regenerative biologics are medical products derived from natural or engineered biological materials that support the repair, regeneration, or replacement of damaged tissues. For example, in October 2025, Aurora Spine Corporation, a Canada-based manufacturing company, introduced a new biologics portfolio through a dedicated division called Aurora Biologics, aimed at improving spinal fusion success. This portfolio includes 100% allograft bone products like TURBO FUSE Fiber Putty and OSTEO BRIDGE Sponge Strips, designed to optimize spinal fusion outcomes. These biologics are combined with Aurora's minimally invasive spinal implant technologies, enhancing surgical efficiency and long-term patient recovery. The launch increases Aurora's biologics offerings by more than 30%, promoting growth and supporting their mission to simplify complex spine care.

In August 2023, Xtant Medical, a US-based medical technology company, acquired specific assets and liabilities related to domestic and international biologics and spinal fixation products from Surgalign Holdings Inc. for an undisclosed sum. This acquisition will enable the combined strengths of both companies to help Xtant Medical broaden its product portfolio and enhance its market presence in the orthopedic and spine surgery sectors. Surgalign Holdings Inc. is a US-based medical technology company that offers spine biologics and spinal fixation products.

Major companies operating in the spine biologics market are Medtronic PLC, Johnson & Johnson Services Inc., Stryker Corporation, Zimmer Biomet Holdings Inc., Integra LifeSciences Corporation, RTI Surgical Inc., LifeNet Health Inc., Xtant Medical Holdings Inc., Kuros Biosciences A.G., Cerapedics Inc, Aziyo Biologics, Bone Biologics Corp., Orthofix Medical Inc., NuVasive Inc., SeaSpine Holdings Corporation, Exactech Inc., DePuy Synthes, Globus Medical Inc., Spine Wave Inc., Osiris Therapeutics Inc.

North America was the largest region in the spine biologics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the spine biologics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the spine biologics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The spine biologics market consists of sales of bone morphogenetic proteins, synthetic bone grafts, and spine fusion systems. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Spine Biologics Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses spine biologics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for spine biologics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The spine biologics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Product: Bone Allografts; Bone Graft Substitute; Platelet Rich Plasma; Bone Marrow Aspirate Therapy
• 2) By Surgery Type: Anterior Cervical Discectomy And Fusion (ACDF); Posterior Lumbar Interbody Fusion (PLIF); Transforaminal Lumbar Interbody Fusion (TLIF); Anterior Lumbar Interbody Fusion (ALIF); Lateral Lumbar Interbody Fusion (LLIF); Other Surgery Types
• 3) By Application: Spinal Fusion; Spinal Non-Union And Fracture Repair; Degenerative Disc Disease Treatment; Other Applications
• 4) By End User: Hospitals; Spinal Surgery Centers; Orthopedic Clinics; Other End Users
• Subsegments:
• 1) By Bone Allografts: Fresh Allografts; Freeze-Dried Allografts
• 2) By Bone Graft Substitute: Synthetic Bone Grafts; Demineralized Bone Matrix (DBM); Calcium Phosphate-Based Grafts; Platelet Rich Plasma (PRP)
• 3) By Bone Marrow Aspirate Therapy: Concentrated Bone Marrow Aspirate; Bone Marrow Concentrates
• Companies Mentioned: Medtronic PLC; Johnson & Johnson Services Inc.; Stryker Corporation; Zimmer Biomet Holdings Inc.; Integra LifeSciences Corporation; RTI Surgical Inc.; LifeNet Health Inc.; Xtant Medical Holdings Inc.; Kuros Biosciences A.G.; Cerapedics Inc; Aziyo Biologics; Bone Biologics Corp.; Orthofix Medical Inc.; NuVasive Inc.; SeaSpine Holdings Corporation; Exactech Inc.; DePuy Synthes; Globus Medical Inc.; Spine Wave Inc.; Osiris Therapeutics Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Spine Biologics Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Spine Biologics Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Spine Biologics Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Spine Biologics Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Biotechnology, Genomics & Precision Medicine
  • 4.1.2 Industry 4.0 & Intelligent Manufacturing
  • 4.1.3 Artificial Intelligence & Autonomous Intelligence
  • 4.1.4 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.5 Sustainability, Climate Tech & Circular Economy
• 4.2. Major Trends
  • 4.2.1 Rising Adoption Of Biologic Bone Grafts In Spinal Fusion
  • 4.2.2 Increasing Use Of Synthetic Bone Graft Substitutes
  • 4.2.3 Growing Preference For Minimally Invasive Spine Procedures
  • 4.2.4 Expansion Of Cell-Based And Regenerative Spine Therapies
  • 4.2.5 Higher Demand For Faster Bone Healing Solutions

5. Spine Biologics Market Analysis Of End Use Industries

• 5.1 Hospitals
• 5.2 Spinal Surgery Centers
• 5.3 Orthopedic Clinics
• 5.4 Ambulatory Surgical Centers
• 5.5 Rehabilitation Centers

6. Spine Biologics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Spine Biologics Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Spine Biologics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Spine Biologics Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Spine Biologics Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Spine Biologics Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Spine Biologics Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Spine Biologics Market Segmentation

• 9.1. Global Spine Biologics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Bone Allografts, Bone Graft Substitute, Bone Marrow Aspirate Therapy
• 9.2. Global Spine Biologics Market, Segmentation By Surgery Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Anterior Cervical Discectomy And Fusion (ACDF), Posterior Lumbar Interbody Fusion (PLIF), Transforaminal Lumbar Interbody Fusion (TLIF), Anterior Lumbar Interbody Fusion (ALIF), Lateral Lumbar Interbody Fusion (LLIF), Other Surgery Types
• 9.3. Global Spine Biologics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Spinal Fusion, Spinal Non-Union And Fracture Repair, Degenerative Disc Disease Treatment, Other Applications
• 9.4. Global Spine Biologics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Hospitals, Spinal Surgery Centers, Orthopedic Clinics, Other End Users
• 9.5. Global Spine Biologics Market, Sub-Segmentation Of Bone Allografts, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Fresh Allografts, Freeze-Dried Allografts
• 9.6. Global Spine Biologics Market, Sub-Segmentation Of Bone Graft Substitute, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Synthetic Bone Grafts, Demineralized Bone Matrix (DBM), Calcium Phosphate-Based Grafts, Platelet Rich Plasma (PRP)
• 9.7. Global Spine Biologics Market, Sub-Segmentation Of Bone Marrow Aspirate Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Concentrated Bone Marrow Aspirate, Bone Marrow Concentrates

10. Spine Biologics Market Regional And Country Analysis

• 10.1. Global Spine Biologics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Spine Biologics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Spine Biologics Market

• 11.1. Asia-Pacific Spine Biologics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Spine Biologics Market, Segmentation By Product, Segmentation By Surgery Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Spine Biologics Market

• 12.1. China Spine Biologics Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Spine Biologics Market, Segmentation By Product, Segmentation By Surgery Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Spine Biologics Market

• 13.1. India Spine Biologics Market, Segmentation By Product, Segmentation By Surgery Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Spine Biologics Market

• 14.1. Japan Spine Biologics Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Spine Biologics Market, Segmentation By Product, Segmentation By Surgery Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Spine Biologics Market

• 15.1. Australia Spine Biologics Market, Segmentation By Product, Segmentation By Surgery Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Spine Biologics Market

• 16.1. Indonesia Spine Biologics Market, Segmentation By Product, Segmentation By Surgery Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Spine Biologics Market

• 17.1. South Korea Spine Biologics Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Spine Biologics Market, Segmentation By Product, Segmentation By Surgery Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Spine Biologics Market

• 18.1. Taiwan Spine Biologics Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Spine Biologics Market, Segmentation By Product, Segmentation By Surgery Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Spine Biologics Market

• 19.1. South East Asia Spine Biologics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Spine Biologics Market, Segmentation By Product, Segmentation By Surgery Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Spine Biologics Market

• 20.1. Western Europe Spine Biologics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Spine Biologics Market, Segmentation By Product, Segmentation By Surgery Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Spine Biologics Market

• 21.1. UK Spine Biologics Market, Segmentation By Product, Segmentation By Surgery Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Spine Biologics Market

• 22.1. Germany Spine Biologics Market, Segmentation By Product, Segmentation By Surgery Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Spine Biologics Market

• 23.1. France Spine Biologics Market, Segmentation By Product, Segmentation By Surgery Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Spine Biologics Market

• 24.1. Italy Spine Biologics Market, Segmentation By Product, Segmentation By Surgery Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Spine Biologics Market

• 25.1. Spain Spine Biologics Market, Segmentation By Product, Segmentation By Surgery Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Spine Biologics Market

• 26.1. Eastern Europe Spine Biologics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Spine Biologics Market, Segmentation By Product, Segmentation By Surgery Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Spine Biologics Market

• 27.1. Russia Spine Biologics Market, Segmentation By Product, Segmentation By Surgery Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Spine Biologics Market

• 28.1. North America Spine Biologics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Spine Biologics Market, Segmentation By Product, Segmentation By Surgery Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Spine Biologics Market

• 29.1. USA Spine Biologics Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Spine Biologics Market, Segmentation By Product, Segmentation By Surgery Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Spine Biologics Market

• 30.1. Canada Spine Biologics Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Spine Biologics Market, Segmentation By Product, Segmentation By Surgery Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Spine Biologics Market

• 31.1. South America Spine Biologics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Spine Biologics Market, Segmentation By Product, Segmentation By Surgery Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Spine Biologics Market

• 32.1. Brazil Spine Biologics Market, Segmentation By Product, Segmentation By Surgery Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Spine Biologics Market

• 33.1. Middle East Spine Biologics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Spine Biologics Market, Segmentation By Product, Segmentation By Surgery Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Spine Biologics Market

• 34.1. Africa Spine Biologics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Spine Biologics Market, Segmentation By Product, Segmentation By Surgery Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Spine Biologics Market Regulatory and Investment Landscape

36. Spine Biologics Market Competitive Landscape And Company Profiles

• 36.1. Spine Biologics Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Spine Biologics Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Spine Biologics Market Company Profiles
  • 36.3.1. Medtronic PLC Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. Stryker Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. Zimmer Biomet Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. Integra LifeSciences Corporation Overview, Products and Services, Strategy and Financial Analysis

37. Spine Biologics Market Other Major And Innovative Companies

• RTI Surgical Inc., LifeNet Health Inc., Xtant Medical Holdings Inc., Kuros Biosciences A.G., Cerapedics Inc, Aziyo Biologics, Bone Biologics Corp., Orthofix Medical Inc., NuVasive Inc., SeaSpine Holdings Corporation, Exactech Inc., DePuy Synthes, Globus Medical Inc., Spine Wave Inc., Osiris Therapeutics Inc.

38. Global Spine Biologics Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Spine Biologics Market

40. Spine Biologics Market High Potential Countries, Segments and Strategies

• 40.1 Spine Biologics Market In 2030 - Countries Offering Most New Opportunities
• 40.2 Spine Biologics Market In 2030 - Segments Offering Most New Opportunities
• 40.3 Spine Biologics Market In 2030 - Growth Strategies
  • 40.3.1 Market Trend Based Strategies
  • 40.3.2 Competitor Strategies

41. Appendix

• 41.1. Abbreviations
• 41.2. Currencies
• 41.3. Historic And Forecast Inflation Rates
• 41.4. Research Inquiries
• 41.5. The Business Research Company
• 41.6. Copyright And Disclaimer